| UHC Surest Medical and Drug | Ilumya® (Tildrakizumab-Asmn) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Infertility Diagnosis, Treatment, and Fertility Preservation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Leqvio® (Inclisiran) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Ocular Photoscreening – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Omnibus Codes – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Pneumatic Compression Devices – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Surgery of the Knee – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Ustekinumab – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Ado-trastuzumab emtansine (Kadcyla™) (09-J1000-90) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Axatilimab (Niktimvo™) Injection (09-J4000-98) | 2026-06-01 |